Top Markets
#1 bitcastle Token bitcastle Token +152.04%
#2 MarsCoin MarsCoin +66.30%
#3 Palladium Network Palladium Network +53.32%
#4 Siren Siren +28.84%
#5 Bedrock Bedrock +22.61%
#6 edgeX edgeX +20.39%
#7 Useless Coin Useless Coin +19.40%
#8 Status Status +16.97%
#9 Asteroid Shiba Asteroid Shiba +16.77%
#10 PondCoin PondCoin +15.92%
Coin of the day
bitcastle Token bitcastle Token
Instellingen
Taal
DUTCH
Valuta
USD
Thema
KemPharm, Inc. KemPharm, Inc.

KemPharm, Inc.

KMPH
Rang in aandelen #18401
KemPharm, Inc. operates as a specialized pharmaceutical firm focused on... KemPharm, Inc. operates as a specialized pharmaceutical firm focused on discovering and advancing proprietary prodrugs to tackle serious medical conditions across the United States. The company employs its innovative Ligand Activated Therapy (LAT) platform to create improved prodrug versions of medications already approved by the FDA, and also to develop prodrugs from existing compounds for potential applications in new disease indications. Its pipeline of investigational prodrugs strategically targets high-need areas such as attention deficit hyperactivity disorder (ADHD), stimulant use disorder, and various rare central nervous system (CNS) disorders, including idiopathic hypersomnia (IH). KP1077, KemPharm's leading experimental compound, is a prodrug of d-methylphenidate, known as serdexmethylphnidate, and is currently in Phase II clinical trials for the treatment of IH and narcolepsy. Additionally, the company is advancing KP879, a prodrug candidate designed to treat stimulant use disorder, which is undergoing Phase I clinical evaluation. KemPharm has also obtained FDA approval for AZSTARYS, a new once-daily ADHD treatment for patients aged six years and older, and for APADAZ, an immediate-release combination product containing benzhydrocodone (a prodrug of hydrocodone) and acetaminophen. The company holds collaboration and license agreements with KVK-Tech, Inc. and Commave Therapeutics SA. Founded in 2006, KemPharm, Inc. is headquartered in Celebration, Florida.
Aandeelprijs
$5.81
Laatst gesynchroniseerd: 2023-02-28
Marktkapitalisatie
$200.14M
Verandering (1 dag)
-0.34%
Verandering (1 jaar)
0.00%
Land
US
Handel KemPharm, Inc. (KMPH)

Categorie

Healthcare
EPS voor KemPharm, Inc. (KMPH)
EPS per 2026 TTM: 0
Volgens de laatste financiële rapporten en de aandelenkoers van KemPharm, Inc. is de huidige EPS van het bedrijf (TTM) 0. Eind 2026 had het bedrijf een EPS van 0, gelijk aan de EPS van 2026 die 0 bedroeg.
EPS-geschiedenis van KemPharm, Inc. van 2026 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH